P1196: ORIENT STUDY: REGIMEN OF ORELABRUTINIB PLUS R-CHOP-LIKE FOR PATIENTS WITH NEWLY DIAGNOSED UNTREATED NON-GCB DLBCL

• Chang-Ju Qu,
• Hai-Ling Liu,
• Rui Zou,
• Na-Na Ping,
• Qian Zhu,
• Xiao Zhang,
• Jia-Jie He,
• De-Pei Wu,
• Zheng-Ming Jin

Affiliations

Chang-Ju Qu

1 The First Affiliated Hospital of Soochow University, Department of Hematology, Suzhou, China

Hai-Ling Liu

2 People’s Hospital of Binhai County, Department of Radiology, Yancheng, China

Rui Zou

3 The First Affiliated Hospital of Soochow University, Department of Hematology, Suzhou, China

Na-Na Ping

1 The First Affiliated Hospital of Soochow University, Department of Hematology, Suzhou, China

Qian Zhu

1 The First Affiliated Hospital of Soochow University, Department of Hematology, Suzhou, China

Xiao Zhang

1 The First Affiliated Hospital of Soochow University, Department of Hematology, Suzhou, China

Jia-Jie He

1 The First Affiliated Hospital of Soochow University, Department of Hematology, Suzhou, China

De-Pei Wu

1 The First Affiliated Hospital of Soochow University, Department of Hematology, Suzhou, China

Zheng-Ming Jin

4 The First Affiliated Hospital of Soochow University, Department of Hematology, Suzhou, China